FDA Regulatory Update: Moving from Outbreak to Prevention

  • Whole Genome Sequencing has revolutionized CDC and FDA disease attribution capabilities.  With better detection comes more outbreaks.
  • The FDA is developing prevention strategies for food categories with recurrent attribution to disease.  These prevention strategies are an opportunity for all stakeholders to focus on prevention in that category.
  • The FDA is ramping up to conduct Root Cause Analysis following foodborne illness outbreaks.  Our reports will communicate what we learn to help firms prevent a recurrence.

Mark Moorman
Director, Office of Food Safety


Mark Moorman is the Director of the Office of Food Safety at the Food and Drug Administration where he leads a team of professionals focused on improving the safety of our food supply.  Prior to joining the FDA, Mark was the Senior Director of Global Scientific & Regulatory Affairs for the Kellogg Company in Battle Creek, MI with responsibilities for emerging food safety and nutrition technical and regulatory issues.  Prior to joining the Kellogg Company in 1998, Mark spent 10 years with Silliker Laboratories as the Technical Director of Microbiology. Mark has his undergraduate and Ph.D. degrees from Michigan State University in Microbiology and Food Science.